Structure Therapeutics Inc. American Depositary Shares Capital Reinvestment Ratio

Latest as of March 2026: 0.08x

Structure Therapeutics Inc. American Depositary Shares capital reinvestment ratio. Structure Therapeutics Inc. American Depositary Shares (GPCR) has a Capital Reinvestment Ratio of 0.08x as of March 2026, meaning it reinvests 0% of its operating cash flow ($15.28 Million) in capital expenditures ($1.19 Million). Check how aggressively does Structure Therapeutics Inc. American Dep reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

$15.28 Million
USD

Capital Expenditures

$1.19 Million
USD

Data as of

Mar 2026
Most recent filing

Structure Therapeutics Inc. American Depositary Shares Capital Reinvestment Ratio by Year (None–None)

Structure Therapeutics Inc. American Depositary Shares capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Structure Therapeutics Inc. American Dep (GPCR) cash conversion ratio.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow